Brief: Orchard Therapeutics Reports 2018 Financial Results And Reviews Recent Business Highlights
21/03/2019 11:23
March 21 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS REPORTS 2018 FINANCIAL RESULTS AND
REVIEWS
RECENT BUSINESS HIGHLIGHTS
* ORCHARD THERAPEUTICS PLC - APPROXIMATELY $340M IN TOTAL
CASH AND
INVESTMENTS
* ORCHARD THERAPEUTICS PLC - THREE LEAD PROGRAMS FOR MLD,
ADA-SCID
AND WAS ON TRACK FOR REGULATORY FILINGS OVER NEXT THREE YEARS
Source text for Eikon: ID:nGNX9TTvd
Further company coverage: ORTX.O
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln